How Does Suboxone Work?
Reviewed by Josie Desmarais, PMHNP-BC · Board-Certified Psychiatric-Mental Health Nurse Practitioner · Last updated August 2026
Suboxone works by combining two medications — buprenorphine and naloxone — to eliminate opioid withdrawal symptoms, suppress cravings, and block the reinforcing effects of other opioids. Buprenorphine partially activates the brain’s opioid receptors to create stability without significant euphoria. Naloxone is a safety mechanism that activates only if the medication is misused by injection. Together, they make Suboxone the most widely prescribed medication for opioid use disorder (OUD) in office-based and telehealth settings.
Short answer: Medication-assisted treatment combines FDA-approved medication with clinical support. A psychiatric provider can assess whether it is right for you and manage it safely.
This mechanism is what makes medication-assisted treatment both effective and safer than going it alone.
The Two Active Ingredients: Buprenorphine and Naloxone
Buprenorphine is a partial mu-opioid agonist — and a kappa-opioid antagonist. It binds to the same mu-opioid receptors that heroin, oxycodone, and fentanyl target, but with critical differences. First, it only partially activates those receptors. Second, it has exceptionally high binding affinity — higher than morphine, heroin, or oxycodone — meaning it displaces other opioids from receptors and is difficult to displace in turn. For more on this, see our guide to whether Suboxone shows up on a drug test.
This partial activation is the mechanism that makes buprenorphine effective without being dangerous. It is strong enough to eliminate withdrawal symptoms and suppress cravings, but the receptor activation plateaus well below the level needed for significant euphoria. People with OUD who take therapeutic doses typically describe feeling “normal” — not high, not sick.
Naloxone is an opioid antagonist — it blocks opioid receptors rather than activating them. In Suboxone’s sublingual form (dissolved under the tongue), naloxone is poorly absorbed through oral mucous membranes. Its oral bioavailability is approximately 3–10%, so under normal prescribed use it has essentially no systemic effect.
The naloxone’s role is abuse deterrence: if someone attempts to inject Suboxone, naloxone enters the bloodstream fully and precipitates acute withdrawal, eliminating any reinforcing effect. This design significantly reduces Suboxone’s diversion value compared to pure buprenorphine products. We cover why Suboxone can make you tired in a separate article.
The Ceiling Effect: Why More Suboxone Does Not Mean More Effect
One of buprenorphine’s most clinically important properties is its ceiling effect on respiratory depression and euphoria. With full opioid agonists — heroin, morphine, fentanyl — increasing the dose produces proportionally stronger effects, which drives both addiction and overdose deaths.
With buprenorphine, the dose-response curve flattens. Beyond approximately 16mg/day, additional dose produces little to no additional effect on mood, sedation, or breathing. This plateau has two significant consequences: If that applies to you, read more about how long Suboxone blocks opiates.
- Safety. Fatal overdose from buprenorphine alone is substantially less likely than from full agonists. Buprenorphine-related deaths almost always involve concurrent use of benzodiazepines, alcohol, or other CNS depressants — not buprenorphine alone.
- Reduced abuse potential. There is limited incentive to take more than the prescribed dose. This property makes Suboxone appropriate for office-based prescribing and telehealth, unlike methadone, which requires daily in-clinic dispensing.
What Suboxone Does for People in MAT
On a stable, appropriate Suboxone dose, people with OUD experience:
- Withdrawal prevention. Buprenorphine’s long half-life (24–42 hours) means a once-daily dose keeps opioid receptors consistently occupied, preventing acute withdrawal symptoms throughout the day.
- Craving suppression. Stable, non-euphoric receptor activation interrupts the cycle of craving, using, crashing, and craving again. Many people describe finally being able to think about something other than opioids.
- Opioid blockade. Because buprenorphine has higher receptor affinity than most full opioid agonists, it effectively blocks other opioids from binding. A person on a therapeutic Suboxone dose who uses heroin or fentanyl will typically not experience the expected effect — which weakens the reinforcement that drives continued use.
Relief from withdrawal symptoms typically begins within 30–60 minutes of the first sublingual dose, with full effect at 1–2 hours. Induction is typically started when a person has a COWS (Clinical Opiate Withdrawal Scale) score of 8 or higher — mild-to-moderate withdrawal — to avoid precipitated withdrawal from displacing opioids still active in receptors.
Sublocade: Monthly Injectable Buprenorphine
For people who prefer not to manage a daily sublingual film, Sublocade (buprenorphine extended-release injection) offers once-monthly subcutaneous administration by a healthcare provider. It delivers sustained buprenorphine release over 28 days from a biodegradable polymer depot under the skin.
Benefits include:
- No daily dosing to manage
- Elimination of diversion risk (provider-administered only)
- Stable blood levels throughout the month
- No naloxone needed — the injectable route itself is the abuse deterrent
Sublocade is available only through the SUBLOCADE REMS Program, which requires certified prescribers. It is not self-administered.
How Suboxone Compares to Methadone
Both buprenorphine (Suboxone) and methadone are FDA-approved for OUD. They differ in meaningful ways:
| Feature | Suboxone (Buprenorphine) | Methadone |
|---|---|---|
| Agonist type | Partial agonist | Full agonist |
| Euphoric potential | Low (ceiling effect) | Higher |
| Prescribing setting | Office-based (PMHNP, MD, DO, NP) + telehealth | Federally regulated OTP clinics only |
| Dosing location | Home (sublingual film) | Daily in-clinic dispensing initially |
| Overdose risk (alone) | Lower | Higher (QTc prolongation, respiratory depression) |
| Telehealth eligible | Yes | No |
For most people with OUD in Florida, Suboxone’s office-based and telehealth prescribing model is the lower-barrier path to starting and maintaining treatment — no daily clinic visits required. Our team also explains how to maximize Suboxone absorption in detail.
This article is for educational purposes only. Suboxone (buprenorphine/naloxone) requires a prescription and ongoing medical supervision. Contact Trust Psychiatry & Wellness at (561) 849-4449 to discuss MAT treatment options.
Frequently Asked Questions
Does Suboxone make you feel high?
Not in people with OUD taking therapeutic doses. The ceiling effect means buprenorphine’s receptor activation plateaus well below the level needed for significant euphoria. People in MAT typically describe feeling “baseline normal” — not high, not sick, just stable. See Does Suboxone Get You High? for a fuller explanation.
How quickly does Suboxone start working?
Most people experience meaningful withdrawal relief within 30–60 minutes of the first sublingual dose. Full stabilization — where cravings are consistently suppressed — typically takes several days as blood levels reach steady state. Learn more about taking gabapentin with Suboxone here.
Is Suboxone safe to take long-term?
Yes. Long-term MAT with buprenorphine is supported by decades of evidence and endorsed by SAMHSA, ASAM, and the American Psychiatric Association. Physical dependence is expected with long-term use — this is different from addiction. Many people remain on MAT indefinitely and that is clinically appropriate.
What happens if someone without opioid dependence takes Suboxone?
In opioid-naive individuals, buprenorphine can produce opioid-like effects — sedation, nausea, and some euphoria. This is why Suboxone is a Schedule III controlled substance requiring a prescription and clinical evaluation.
Can Suboxone be used for pain management?
Buprenorphine is FDA-approved for pain in different formulations (Butrans transdermal patch, Belbuca buccal film). Suboxone itself is specifically approved for OUD. Your provider can discuss whether buprenorphine-based pain management is appropriate for your situation. You may also want to understand who can prescribe Suboxone.
Learn Whether Suboxone Is Right for You
Understanding how it works is step one — finding the right treatment path is step two. At Trust Psychiatry & Wellness, Josie Desmarais, PMHNP-BC provides individualized medication-assisted treatment and substance use disorder care via telehealth across Florida. No daily clinic trips. No judgment. Call (561) 849-4449 or contact us to discuss your options.
Ready to Schedule a Psychiatric Evaluation?
Reviewed by · Board-Certified Psychiatric-Mental Health Nurse Practitioner
Josie Desmarais is a board-certified psychiatric-mental health nurse practitioner (PMHNP-BC) at Trust Psychiatry – Mental Health West Palm Beach. She provides psychiatric evaluation and medication management, and helps patients understand how medication-assisted treatment supports recovery from opioid use, through secure telepsychiatry for adults across Florida.